Pyxis Oncology Inc Cash Flow-to-Debt Ratio
Pyxis Oncology Inc cash flow-to-debt ratio. Pyxis Oncology Inc (PYXS) has a Cash Flow-to-Debt Ratio of -0.36x as of September 2025, meaning its operating cash flow of $-13.28 Million could theoretically repay 0% of its total liabilities ($36.83 Million) in one year. See Pyxis Oncology Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Pyxis Oncology Inc (2019–2024)
Cash flow-to-debt ratio of Pyxis Oncology Inc from 2019 to 2024. Historical debt coverage capacity for Pyxis Oncology Inc across 6 annual periods. Check Pyxis Oncology Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Pyxis Oncology Inc Cash Flow-to-Debt Ratio by Year (2019–2024)
Pyxis Oncology Inc cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for Pyxis Oncology Inc. For the full cash flow conversion analysis, see PYXS operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.58x | $-57.67 Million | $36.43 Million | ▼ -7.5% |
| 2023 | -1.47x | $-70.71 Million | $48.02 Million | ▲ +16.7% |
| 2022 | -1.77x | $-89.33 Million | $50.55 Million | ▲ +6.4% |
| 2021 | -1.89x | $-35.33 Million | $18.71 Million | ▼ -383.0% |
| 2020 | -0.39x | $-10.08 Million | $25.80 Million | ▼ -296.0% |
| 2019 | -0.10x | $-2.24 Million | $22.68 Million | — |